Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Masatoshi,Kudo

第一单位： Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan. m-kudo@med.kinki.ac.jp.

作者： Masatoshi,Kudo ^[1] ; Etsuro,Hatano ^[2] ; Shinichi,Ohkawa ^[3] ; Hirofumi,Fujii ^[4] ; Akihide,Masumoto ^[5] ; Junji,Furuse ^[6] ; Yoshiyuki,Wada ^[7] ; Hiroshi,Ishii ^[8] ; Shuntaro,Obi ^[9] ; Shuichi,Kaneko ^[10] ; Seiji,Kawazoe ^[11] ; Osamu,Yokosuka ^[12] ; Masafumi,Ikeda ^[13] ; Katsuaki,Ukai ^[14] ; Sojiro,Morita ^[15] ; Akihito,Tsuji ^[16] ; Toshihiro,Kudo ^[17] ; Mitsuo,Shimada ^[18] ; Yukio,Osaki ^[19] ; Ryosuke,Tateishi ^[20] ; Gen,Sugiyama ^[21] ; Paolo Benjamin,Abada ^[22] ; Ling,Yang ^[23] ; Takuji,Okusaka ^[24] ; Andrew Xiuxuan,Zhu ^[25]

作者单位： Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan. m-kudo@med.kinki.ac.jp. ^[1] Kyoto University Hospital, Kyoto, Japan. ^[2] Kanagawa Cancer Center, Yokohama, Kanagawa, Japan. ^[3] Jichi Medical University, Shimotsuke, Tochigi, Japan. ^[4] Aso Iizuka Hospital, Fukuoka, Japan. ^[5] Kyorin University School of Medicine Hospital, Tokyo, Japan. ^[6] National Hospital Organization Kyushu Medical Center, Fukuoka, Japan. ^[7] The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. ^[8] Kyoundo Hospital, Sasaki Institute, Tokyo, Japan. ^[9] Kanazawa University Hospital, Ishikawa, Japan. ^[10] Saga-Ken Medical Centre Koseikan, Saga, Japan. ^[11] Chiba University Hospital, Chiba, Japan. ^[12] National Cancer Center Hospital East, Chiba, Japan. ^[13] Sendai Medical Center, Sendai, Miyagi, Japan. ^[14] Kochi Health Sciences Center, Kochi, Japan. ^[15] Kagawa University Hospital, Takamatsu, Kagawa, Japan. ^[16] Osaka University Hospital, Osaka, Japan. ^[17] Tokushima University Hospital, Tokushima, Japan. ^[18] Osaka Red Cross Hospital, Osaka, Japan. ^[19] The University of Tokyo Hospital, Tokyo, Japan. ^[20] Kurume University Medical Center, Fukuoka, Japan. ^[21] Eli Lilly and Company, Indianapolis, IN, USA. ^[22] Eli Lilly and Company, Bridgewater, NJ, USA. ^[23] National Cancer Center Hospital, Tokyo, Japan. ^[24] Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. ^[25]

关键词 Clinical trial Japan Liver neoplasms Vascular endothelial growth factor receptor?2 α-Fetoprotein